SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-014786
Filing Date
2023-04-26
Accepted
2023-04-26 16:06:03
Documents
5
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A pstx_def_14a_2023.htm DEF 14A 1091471
2 GRAPHIC img248980082_0.jpg GRAPHIC 32204
3 GRAPHIC img248980082_1.jpg GRAPHIC 32204
4 GRAPHIC img248980082_2.jpg GRAPHIC 559348
5 GRAPHIC img248980082_3.jpg GRAPHIC 294904
  Complete submission text file 0000950170-23-014786.txt   2358037
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39376 | Film No.: 23849719
SIC: 2836 Biological Products, (No Diagnostic Substances)